Journal of the European Academy of Dermatology and Venereology: Vol 37, No 2

I consent to Wiley Online Library’s Terms of Use and processing of my personal data as disclosed in Wiley’s Privacy Policy.I consent to my personal information being transferred outside of the People’s Republic of China as laid out in Wiley’s Privacy Policy.*(Optional) I consent to special offers, newsletter & promotions from Wiley. See Privacy Policy for more details.

Tools

Journal Metrics

More from this journal

Click on the Altmetric banner to view the latest trending articles from Journal of the European Academy of Dermatology & Venereology

Publishing Open Access? Your fees may be covered

EADV Journals

Journal of the European Academy of Dermatology and Venereology

Journal list menu

Tools

Follow journal

Journal of the European Academy of Dermatology and Venereology: Volume 37, Issue 2

Download PDFs

Issue Information

Issue Information

EDITOR’S PICKS

Editor's Picks February 2023

EDITORIAL

Sports, football and dermatology

COMMENTARIES

Surveillance, CDKN2A and survival of familial melanoma

Zinc supplements may prevent and treat cutaneous toxicities induced by epidermal growth factor receptor inhibitors

HISTORICAL PERSPECTIVES

Pioneers in Dermatology and Venereology: An Interview with Professor Annamari Ranki

Fortuitous discoveries in dermatology

REVIEW ARTICLES

Evaluation of risk in chronic cutaneous inflammatory conditions for malignant transformation

Strategies for the enhancement of nail plate permeation of drugs to treat onychomycosis

Prevalence, comorbidities and mortality of generalized pustular psoriasis: A literature review

Skin hyperpigmentation after sclerotherapy with polidocanol: A systematic review

ORIGINAL ARTICLES AND SHORT REPORTS

ONCOLOGY

Melanoma-specific survival before and after inclusion in a familial melanoma dermatologic surveillance program in CDKN2A mutation carriers and non-carriers

Patient presentation, skin biopsy utilization and cutaneous malignant melanoma incidence and mortality in northern Italy: Trends and correlations

Amelanotic/hypomelanotic lentigo maligna: Dermoscopic and confocal features predicting diagnosis

Impact of blood involvement on efficacy and time to response with mogamulizumab in mycosis fungoides and Sézary syndrome

Dermoscopy of haemosiderotic/aneurysmal dermatofibroma: A morphological study of 110 cases

Zinc deficiency associated with cutaneous toxicities induced by epidermal growth factor receptor tyrosine kinase inhibitor therapy in patients with lung adenocarcinoma

PSORIASIS

Mitochondrial dysfunction: The pathological link between psoriasis and insulin resistance?

Efficacy and safety of apremilast in patients with limited skin involvement, plaque psoriasis in special areas and impaired quality of life: Results from the EMBRACE randomized trial

ALLERGY AND ECZEMA

Treatment patterns and outcomes in patients with chronic urticaria during pregnancy: Results of PREG-CU, a UCARE study

The effects of systemic immunomodulatory treatments on COVID-19 outcomes in patients with atopic dermatitis: Results from the global SECURE-AD registry

Temporal shifts of the microbiome associated with antibiotic treatment of purpuric drug eruptions related to epidermal growth factor receptor inhibitors

INFECTIOUS DISEASES/VENEREOLOGY

Comparison of molecular and serological assays on cerebrospinal fluid for the diagnosis of neurosyphilis

ACNE/HIDRADENITIS SUPPURATIVA

Development and validation of IHS4-55, an IHS4 dichotomous outcome to assess treatment effect for hidradenitis suppurativa

GENETICS

Epidemiology of inherited epidermolysis bullosa in Germany

Genotype and phenotype correlations in 441 patients with epidermolysis bullosa from China

Porokeratosis is one of the most common genodermatoses and is associated with an increased risk of keratinocyte cancer and melanoma

PHLEBOLOGY

A prospective, multicentre study to assess frailty in elderly patients with leg ulcers (GERAS study)

Superficial (nodular) thrombophlebitis as a heterogeneous entity with distinctive clinico-pathological aspects: Correlation with the underlying conditions

PSYCHODERMATOLOGY

Patient Unique Stigmatization Holistic tool in dermatology (PUSH-D): Development and validation of a dermatology-specific stigmatization assessment tool

CORRIGENDA

Corrigendum

Stevens-Johnson syndrome induced by Vaxvetria (AZD1222) COVID-19 vaccine

Corrigendum

Efficacy and safety of topical finasteride spray solution for male androgenetic alopecia: a phase III, randomized, controlled clinical trial

ANNOUNCEMENTS

Announcement

Announcement

COVID-19 SPECIAL FORUM - LETTER TO THE EDITOR

Regression of common viral warts in an immunocompetent child and an immunosuppressed adult relative after mRNA BNT162b2 COVID-19 vaccine

A case of Anti-MDA5-Positive dermatomyositis after inactivated COVID-19 vaccine

Reply to ‘Impact of the French COVID-19 pandemic lockdown on newly diagnosed melanoma delay and severity’ by R. Molinier et al.

Impact of the French COVID-19 pandemic lockdown on newly diagnosed melanoma delay and severity

Reply to A. Ruggiero et al. to our article ‘Impact of the French COVID-19 pandemic lockdown on newly diagnosed melanoma delay and severity’

Reply to A. Ruggiero et al. to our article ‘Impact of the French COVID-19 pandemic lockdown on newly diagnosed melanoma delay and severity’

A cross-sectional study of dermatologists' attitudes towards COVID-19 vaccination in patients with immunobullous diseases

Severe bullous pemphigoid following Covid-19 vaccination resistant to rituximab and successfully treated with dupilumab

Reply to: ‘Severe bullous pemphigoid following Covid-19 vaccination resistant to rituximab and successfully treated with dupilumab’ by Baffa et al.

Reply to: ‘Severe bullous pemphigoid following Covid-19 vaccination resistant to rituximab and successfully treated with dupilumab’ by Baffa et al.

COVID-19 vaccine side effects in patients with and without atopic dermatitis

Reply to ‘A case of pityriasis lichenoides et varioliformis acuta developed after first dose of Oxford-AstraZeneca COVID-19 vaccine’

A case of pityriasis lichenoides et varioliformis acuta developed after first dose of Oxford–AstraZeneca COVID-19 vaccine

Female genital mucosal lesions associated with COVID-19 vaccination: A brief review of the literature

Gianotti-crosti syndrome after COVID-19 vaccination

LETTERS TO THE EDITOR

A prospective case control study of resistance to rifampicin, dapsone and ofloxacin in Type 1 and Type 2 leprosy reactions and the therapeutic impact of modified treatment regimen on reactions

Halo-like phenomenon in neurofibromatosis type 1: A potential new diagnostic criterion

Response letter to: Halo-like phenomenon in neurofibromatosis type 1: A potential new diagnostic criterion

Can people take high-quality images using mobile dermatoscopes at home on easy-to-see and difficult-to-see body areas?